Supporting women with adherence to adjuvant endocrine therapy (SWEET): a feasibility study of the HT&Me intervention

We assessed acceptability and feasibility of an evidence-based, theory-informed, patient-centred intervention (HT&Me) designed to support AET adherence and improve quality-of-life. The single arm study aimed to recruit 45 women with stage I-III breast cancer within 14 weeks of first AET prescription. After completing baseline questionnaires, participants received HT&Me, comprising: (i) short animation; (ii) two personalised consultations with a nurse/practitioner; (iii) an interactive web-app; and (iv) email/text reminders. Participants completed follow-up questionnaires. Samples of women (n=20) and health professionals (HPs; n=14) were interviewed.